Status:
COMPLETED
0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia
Lead Sponsor:
National Cheng-Kung University Hospital
Conditions:
Hospital-acquired Pneumonia
Eligibility:
All Genders
20-100 years
Phase:
NA
Brief Summary
Chlorhexidine is a effective strategy in reducing ventilator associated pneumonia. However, it is unclear if prophylactic 0.12% chlorhexidine oral rinse can reduce the risk of non-ventilator hospital-...
Detailed Description
Participants will be classified into three groups, applied twice a day by care givers. Oral colonization will be tested in the baseline, day-3, day-7, and at the discharge. Quantitation of colonizatio...
Eligibility Criteria
Inclusion
- Hospitalized patients \> 20 years old without ventilator
Exclusion
- known hypersensitivity to or intolerance of Chlorhexidine or Listerine
Key Trial Info
Start Date :
May 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT04403971
Start Date
May 25 2020
End Date
December 31 2020
Last Update
December 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yen-Chin Chen
Tainan, Taiwan, 722